Fluorine-19 NMR imaging of glucose metabolism

T. Nakada, Ingrid Kwee, P. J. Card, N. A. Matwiyoff, B. V. Griffey, R. H. Griffey

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Metabolic imaging reflecting glucose metabolism in the glycolytic and aldose reductase sorbitol (ARS) pathways was performed noninvasively in rat using fluorinated glucose analogs, 2-fluoro-2-deoxy-D-glucose (2-FDG) or 3-fluoro-3-deoxy-D-glucose (3-FDG), and fluorine-19 (19F) nuclear magnetic resonance (NMR) imaging. 19F images of 2-FDG-6-phosphate, a main metabolite of 2-FDG in the glycolytic pathway, showed high glucose utilization in the brain, spinal cord, and heart. Images of 3-fluoro-3-deoxy-D-sorbitol (3-FDSL), a main metabolite of 3-FDG in the ARS pathway, demonstrated the heterogeneous nature of the spatial distribution of aldose reductase activities, being highest in the brain and lens. The extremely low toxicity of 3-FDG indicates promise for clinical application of 3-FDG NMR imaging.

Original languageEnglish (US)
Pages (from-to)307-313
Number of pages7
JournalMagnetic Resonance in Medicine
Volume6
Issue number3
StatePublished - 1988

Fingerprint

Aldehyde Reductase
Sorbitol
Magnetic Resonance Spectroscopy
Glucose
Fluorodeoxyglucose F18
Magnetic Resonance Imaging
Fluorine
Brain
Lenses
Spinal Cord
3-deoxy-3-fluoro-D-glucose
Fluorine-19 Magnetic Resonance Imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Nakada, T., Kwee, I., Card, P. J., Matwiyoff, N. A., Griffey, B. V., & Griffey, R. H. (1988). Fluorine-19 NMR imaging of glucose metabolism. Magnetic Resonance in Medicine, 6(3), 307-313.

Fluorine-19 NMR imaging of glucose metabolism. / Nakada, T.; Kwee, Ingrid; Card, P. J.; Matwiyoff, N. A.; Griffey, B. V.; Griffey, R. H.

In: Magnetic Resonance in Medicine, Vol. 6, No. 3, 1988, p. 307-313.

Research output: Contribution to journalArticle

Nakada, T, Kwee, I, Card, PJ, Matwiyoff, NA, Griffey, BV & Griffey, RH 1988, 'Fluorine-19 NMR imaging of glucose metabolism', Magnetic Resonance in Medicine, vol. 6, no. 3, pp. 307-313.
Nakada T, Kwee I, Card PJ, Matwiyoff NA, Griffey BV, Griffey RH. Fluorine-19 NMR imaging of glucose metabolism. Magnetic Resonance in Medicine. 1988;6(3):307-313.
Nakada, T. ; Kwee, Ingrid ; Card, P. J. ; Matwiyoff, N. A. ; Griffey, B. V. ; Griffey, R. H. / Fluorine-19 NMR imaging of glucose metabolism. In: Magnetic Resonance in Medicine. 1988 ; Vol. 6, No. 3. pp. 307-313.
@article{a9dd57670de74ee3b3e4a341af2c5a02,
title = "Fluorine-19 NMR imaging of glucose metabolism",
abstract = "Metabolic imaging reflecting glucose metabolism in the glycolytic and aldose reductase sorbitol (ARS) pathways was performed noninvasively in rat using fluorinated glucose analogs, 2-fluoro-2-deoxy-D-glucose (2-FDG) or 3-fluoro-3-deoxy-D-glucose (3-FDG), and fluorine-19 (19F) nuclear magnetic resonance (NMR) imaging. 19F images of 2-FDG-6-phosphate, a main metabolite of 2-FDG in the glycolytic pathway, showed high glucose utilization in the brain, spinal cord, and heart. Images of 3-fluoro-3-deoxy-D-sorbitol (3-FDSL), a main metabolite of 3-FDG in the ARS pathway, demonstrated the heterogeneous nature of the spatial distribution of aldose reductase activities, being highest in the brain and lens. The extremely low toxicity of 3-FDG indicates promise for clinical application of 3-FDG NMR imaging.",
author = "T. Nakada and Ingrid Kwee and Card, {P. J.} and Matwiyoff, {N. A.} and Griffey, {B. V.} and Griffey, {R. H.}",
year = "1988",
language = "English (US)",
volume = "6",
pages = "307--313",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Fluorine-19 NMR imaging of glucose metabolism

AU - Nakada, T.

AU - Kwee, Ingrid

AU - Card, P. J.

AU - Matwiyoff, N. A.

AU - Griffey, B. V.

AU - Griffey, R. H.

PY - 1988

Y1 - 1988

N2 - Metabolic imaging reflecting glucose metabolism in the glycolytic and aldose reductase sorbitol (ARS) pathways was performed noninvasively in rat using fluorinated glucose analogs, 2-fluoro-2-deoxy-D-glucose (2-FDG) or 3-fluoro-3-deoxy-D-glucose (3-FDG), and fluorine-19 (19F) nuclear magnetic resonance (NMR) imaging. 19F images of 2-FDG-6-phosphate, a main metabolite of 2-FDG in the glycolytic pathway, showed high glucose utilization in the brain, spinal cord, and heart. Images of 3-fluoro-3-deoxy-D-sorbitol (3-FDSL), a main metabolite of 3-FDG in the ARS pathway, demonstrated the heterogeneous nature of the spatial distribution of aldose reductase activities, being highest in the brain and lens. The extremely low toxicity of 3-FDG indicates promise for clinical application of 3-FDG NMR imaging.

AB - Metabolic imaging reflecting glucose metabolism in the glycolytic and aldose reductase sorbitol (ARS) pathways was performed noninvasively in rat using fluorinated glucose analogs, 2-fluoro-2-deoxy-D-glucose (2-FDG) or 3-fluoro-3-deoxy-D-glucose (3-FDG), and fluorine-19 (19F) nuclear magnetic resonance (NMR) imaging. 19F images of 2-FDG-6-phosphate, a main metabolite of 2-FDG in the glycolytic pathway, showed high glucose utilization in the brain, spinal cord, and heart. Images of 3-fluoro-3-deoxy-D-sorbitol (3-FDSL), a main metabolite of 3-FDG in the ARS pathway, demonstrated the heterogeneous nature of the spatial distribution of aldose reductase activities, being highest in the brain and lens. The extremely low toxicity of 3-FDG indicates promise for clinical application of 3-FDG NMR imaging.

UR - http://www.scopus.com/inward/record.url?scp=0023906790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023906790&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 307

EP - 313

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 3

ER -